Cargando…

Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma

BACKGROUND: Individuals with hepatocellular carcinoma (HCC) are at risk of tumor recurrence after surgical resection, which affects their survival. The aim of the present study was to establish a model for predicting tumor progression in patients with HCC. METHODS: To develop and validate the effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Lihua, Liu, Xiaoli, Jiang, Yuyong, Wang, Xinhui, Wang, Xianbo, Yang, Zhiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654545/ https://www.ncbi.nlm.nih.gov/pubmed/33192075 http://dx.doi.org/10.2147/OTT.S275304

Ejemplares similares

A Novel Prognostic Score Based on Artificial Intelligence in Hepatocellular Carcinoma: A Long-Term Follow-Up Analysis
por: Liu, Xiaoli, et al.
Publicado: (2022)

Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
por: Wang, Xinhui, et al.
Publicado: (2020)

Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B
por: Yu, Lihua, et al.
Publicado: (2019)

Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis
por: Liu, Xiaoli, et al.
Publicado: (2018)

HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus
por: He, Lingling, et al.
Publicado: (2017)

TIGIT(+) TIM-3(+) NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
por: Yu, Lihua, et al.
Publicado: (2021)

Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: He, Lingling, et al.
Publicado: (2017)

Comparative effectiveness and safety of traditional Chinese medicine supporting Qi and enriching blood for cancer related anemia in patients not receiving chemoradiotherapy: a meta-analysis and systematic review
por: Dang, Zhibo, et al.
Publicado: (2018)

Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2023)

A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy
por: Zhou, Dongdong, et al.
Publicado: (2021)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer
por: Liu, Xiaoli, et al.
Publicado: (2017)

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model
por: Yan, Huiwen, et al.
Publicado: (2022)

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
por: Wang, Xinhui, et al.
Publicado: (2021)

Early risk warning system for distant metastasis of hepatitis B virus-associated hepatocellular carcinoma with portal vein tumor thrombus
por: Li, Mengge, et al.
Publicado: (2020)

Immunomodulatory Effect of Traditional Chinese Medicine Combined with Systemic Therapy on Patients with Liver Cancer: A Systemic Review and Network Meta-analysis
por: Pu, Qing, et al.
Publicado: (2022)

A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8(+)T Cell Counts and Age
por: Wu, Yuan, et al.
Publicado: (2023)

A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma
por: Liu, Yao, et al.
Publicado: (2018)

Dynamic Nomogram for Predicting Macrovascular Invasion of Patients with Unresectable Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Yan, Huiwen, et al.
Publicado: (2022)

Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8(+)T Cell Counts
por: Pu, Qing, et al.
Publicado: (2022)

Machine learning-based model for predicting the esophagogastric variceal bleeding risk in liver cirrhosis patients
por: Hou, Yixin, et al.
Publicado: (2023)

The impact of thyroid hormones on patients with hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2017)

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
por: Xie, Yuqing, et al.
Publicado: (2022)

Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis
por: Yan, Fengna, et al.
Publicado: (2020)

Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy
por: Ma, Yuqin, et al.
Publicado: (2017)

The Effect of ThyroidߚStimulating Hormone on Stage of Differentiated Thyroid Carcinoma
por: Soleimanisardoo, Laya, et al.
Publicado: (2021)

Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma
por: Gu, Yushen, et al.
Publicado: (2021)

Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
por: Wang, Ruihua, et al.
Publicado: (2018)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
por: Ju, Yanli, et al.
Publicado: (2023)

Thyroid Stimulating Hormone Receptor
por: Tuncel, Murat
Publicado: (2017)

Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels
por: Babić Leko, Mirjana, et al.
Publicado: (2021)

Expression and Clinical Significance of Thyroid-stimulating hormone receptor in the Subtypes of Papillary thyroid carcinomas
por: Shen, Wei, et al.
Publicado: (2023)

Serum levels of thyroid hormones and thyroid stimulating hormone in patients with biliogenic and hyperlipidaemic acute pancreatitis: Difference and value in predicting disease severity
por: Yang, Ning, et al.
Publicado: (2016)

Correlation of thyroid hormone measurements with thyroid stimulating hormone stimulation test results in radioiodine‐treated cats
por: Wakeling, Jennifer, et al.
Publicado: (2020)

Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation
por: Fröhlich, Eleonore, et al.
Publicado: (2023)

The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/ Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
por: Demir, Fadime, et al.
Publicado: (2019)

KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma
por: Shi, Lei, et al.
Publicado: (2016)

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor
por: Zheng, Haitao, et al.
Publicado: (2016)

Roxadustat and thyroid-stimulating hormone suppression
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qvca06dgojnf4jgdeh58eelnqb